We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

First Data on Using a Therapeutic Form of ACE2 To Treat COVID-19 Published

Product News   Sep 25, 2020

 
First Data on Using a Therapeutic Form of ACE2 To Treat COVID-19 Published
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

AMSBIO Launches New Human iPSC-Derived Cells and iPSC Differentiation Reagent Kits

Product News

AMSBIO is launching a new range of human iPSC-derived cells and human iPSC differentiation reagent kits optimized for high-throughput experiments in areas including drug discovery and toxicity screening.

READ MORE

AMSBIO Announces StemFit® for Mesenchymal Stem Cells

Product News

AMSBIO announces StemFit® for MSC - a new and optimized medium for expansion and maintenance of Mesenchymal Stem Cells.

READ MORE

SARS-CoV-2 Antibodies and Antigens for Diagnostic Kit Development

Product News

AMSBIO has further expanded its product range to help in the fight against COVID-19 with the introduction of a new range of SARS-CoV-2 antibodies and antigens to aid development of new immunoassay diagnostic kits.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE